Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Talat Imran
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:developedBy |
oral drug delivery platform
|
| gptkbp:focusesOn |
oral biologics delivery
|
| gptkbp:foundedBy |
gptkb:Mir_Imran
|
| gptkbp:foundedYear |
2012
|
| gptkbp:headquartersLocation |
gptkb:San_Jose,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Rani Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
RaniPill
|
| gptkbp:stockSymbol |
gptkb:RANI
|
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:website |
https://www.ranitherapeutics.com/
|
| gptkbp:bfsParent |
gptkb:Horizon_Ventures
gptkb:Mir_Imran |
| gptkbp:bfsLayer |
7
|